Oct 24 (Reuters) - Resverlogix Corp
* Resverlogix Corp - entered into a Right of First Refusal Agreement with Hepalink USA Inc
* Resverlogix Corp - Hepalink USA paid $8 million to Resverlogix in consideration for right of first refusal granted
* Resverlogix - during first 60 day period, deal may only be terminated upon mutual agreement; thereafter, agreement may be terminated by either party
* Resverlogix-Hepalink USA granted Right of First Refusal in connection with licensing of right to develop, among others, products having RVX-208 in U.S.
* Resverlogix-Hepalink USA granted Right of First Refusal related to licensing of right to develop products with RVX-208 in U.S. until April 15, 2019 Source text for Eikon: Further company coverage: